^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Pituitary Gland Carcinoma

Related cancers:
1d
DDAVP for Pituitary Adenoma (clinicaltrials.gov)
P=N/A, N=22, Recruiting, National Institute of Neurological Disorders and Stroke (NINDS) | Not yet recruiting --> Recruiting
Enrollment open
2d
DDAVP for Pituitary Adenoma (clinicaltrials.gov)
P=N/A, N=22, Not yet recruiting, National Institute of Neurological Disorders and Stroke (NINDS) | Trial completion date: Apr 2026 --> Feb 2028 | Trial primary completion date: Apr 2026 --> Feb 2028
Trial completion date • Trial primary completion date
3d
New trial
4d
Isolated Intracranial Rosai-Dorfman Disease Mimicking Sellar Pituitary Adenoma: a case report and literature review. (PubMed, BMC Neurol)
The clinical manifestations of intrasellar RDD are insidious and lack specificity, making it easy to confuse with common pituitary space-occupying lesions. Currently, surgical resection remains the gold standard for definitive diagnosis and is the primary therapeutic intervention, long-term follow-up is crucial for monitoring recurrence.
Journal
|
CD68 (CD68 Molecule)
5d
Clonorchis sinensis promotes hepatocellular carcinoma progression via a potential PTTG1-β-catenin-c-MYC axis. (PubMed, Food Waterborne Parasitol)
These findings suggest that C. sinensis infection promotes HCC malignancy and stemness via ESP-induced PTTG1 expression, potentially through Wnt/β-catenin signaling and its downstream targets, including c-MYC and CD44, particularly in the context of the specific carcinogen-driven models used in this study. Further exploration of the PTTG1 pathway may offer insights into potential therapeutic strategies for C. sinensis-associated HCC.
Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • PTTG1 (PTTG1 Regulator Of Sister Chromatid Separation, Securin)
5d
MALAT1 rs619586 as a potential genetic marker of pituitary adenoma susceptibility and aggressiveness. (PubMed, Front Endocrinol (Lausanne))
Additionally, the observed relationship between p53 expression and tumor proliferation highlights its potential role in PA tumorigenesis. Further studies are needed to confirm these associations and clarify the underlying molecular mechanisms.
Journal
|
TP53 (Tumor protein P53) • MALAT1 (Metastasis associated lung adenocarcinoma transcript 1)
6d
DNMT3A R882C variant in a patient with a presumed pineal gland tumor, highlighting potential tumor susceptibility in Tatton-Brown-Rahman syndrome. (PubMed, Cancer Genet)
Although the lesion lacks histopathologic confirmation and a sporadic occurrence cannot be excluded, this observation raises the possibility that germline DNMT3A alterations may predispose to a broader range of tumors than previously recognized. This report underscores the need for continued documentation of unusual tumor presentations in TBRS to further elucidate the biology of DNMT3A-related tumorigenesis.
Journal
|
DNMT3A (DNA methyltransferase 1)
7d
Multiple endocrine neoplasia with an atypical clinical course and a MEN1 gene variant of uncertain pathogenicity: A case report. (PubMed, Medicine (Baltimore))
This case underscores the importance of considering MEN1 even in elderly patients with atypical manifestations, emphasizes the value of integrating prior medical history into diagnosis, and suggests a potential role of rs2959656 in MEN1 pathogenesis.
Journal
|
MEN1 (Menin 1)
8d
Cancer Risk in Patients with Acromegaly: Insights from a Single Center in Ankara. (PubMed, J Clin Med)
In this study, we demonstrated that thyroid cancer is the most common malignancy in Turkish acromegalic patients, consistent with the results of previous studies. The increased cancer risk in acromegalic patients did not correlate with age, sex, age at diagnosis, time to diagnosing acromegaly, duration of acromegaly, or GH and IGF-1 levels at diagnosis.
Journal
|
IGF1 (Insulin-like growth factor 1)
8d
Identification and Validation of Signature Genes in Invasiveness-Associated Modules of Nonfunctioning Pituitary Adenomas. (PubMed, Biomedicines)
Although the signature demonstrated promising diagnostic potential, its transcriptional repression is unlikely to be primarily explained by DNA methylation. These findings provide candidate markers and mechanistic hypotheses for understanding invasive NFPA and developing risk-stratification tools.
Journal
|
LRRC1 (Leucine Rich Repeat Containing 1)
8d
CDK8 phosphorylates SOX2 to maintain stemness of pituitary adenoma. (PubMed, Oncogene)
Moreover, pharmacological inhibition of CDK8 markedly suppressed PA cell proliferation and viability in GH3 and MMQ cell lines, primary human PA cells, and murine xenograft models. These findings revealed a novel regulatory mechanism of PA stemness and provided a promising therapeutic target for PA.
Journal
|
SOX2
9d
Calcitonin Gene-Related Peptide (CGRP) Expression in Somatotroph Adenomas: Implications for Clinical Course and Treatment Outcomes. (PubMed, Neuroendocrinology)
CGRP was found to be notably present in somatotropin-producing adenoma tissues, yet it was entirely absent from non-functioning adenoma tissues. The detection of CGRP within adenoma tissue could correlate with an increased incidence of persistent headaches and diminished postoperative remission probabilities in acromegaly.
Journal
|
ER (Estrogen receptor)